Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CTSK | P43235 | 7/20 | 0.53 |
| ▸ | CTSL | P07711 | 3/20 | 0.53 |
| ▸ | CTSS | P25774 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
| ▸ | ELANE | P08246 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | PLAU | P00749 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5898129 | 0.90 | CTSK (0.59) | CTSKCTSLCTSSNPC1RAB9A | |
| SCHEMBL5325045 | 0.90 | CTSK (0.59) | CTSKCTSLCTSSNPC1RAB9A | |
| SCHEMBL5325046 | 0.90 | CTSK (0.59) | CTSKCTSLCTSSNPC1RAB9A | |
| SCHEMBL1644719 | 0.86 | TP53 (0.53) | ATMCTSKCTSLCTSSNPC1 | |
| SCHEMBL3483760 | 0.86 | TP53 (0.53) | ATMCTSKCTSLCTSSNPC1 | |
| SCHEMBL3487855 | 0.86 | TP53 (0.53) | ATMCTSKCTSLCTSSNPC1 | |
| SCHEMBL10425602 | 0.86 | ATM (0.62) | ATMCA1CA2ACHEALDH1A1 | |
| SCHEMBL3248431 | 0.85 | ATM (0.76) | ATMCA1CA2ACHEALDH1A1 | |
| SCHEMBL3248429 | 0.85 | ATM (0.76) | ATMCA1CA2ACHEALDH1A1 | |
| SCHEMBL4870019 | 0.84 | CTSK (0.50) | ATMALDH1A1CTSKCTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7026515-B2 | Optically active amine derivatives and preparation process therefor | MITSUI CHEMICALS, INC. (JP) | 2006-04-11 | — | — | US | disclosed |
| US-20040030144-A1 | Optically active amine derivative and method of synthesis | MITSUI CHEMICALS, INC. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1340743-A1 | OPTICALLY ACTIVE AMINE DERIVATIVE AND METHOD OF SYNTHESIS | Mitsui Chemicals, Inc. (JP) | 2003-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040030144-A1 | Optically active amine derivative and method of synthesis | ALDH7A1, AADAT, KMO | ATM 2722/4885CA1 3690/4885CA2 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.